You Searched For "biopharma stocks" and got 20 results
Sort By:
3 mins read
How 4 possible presidential election results could impact stocks
UBS says a Kamala Harris presidency and split Congress is the most likely outcome, and thinks that …
Filip De Mott
1 min read
This overlooked obesity-drug stock has 80% upside, JPMorgan says
JPMorgan said it expects Structure Therapeutics' oral GLP-1 weight loss drug candidate to generate …
Matthew Fox
1 min read
A small biopharma stock has spiked 187% as retail traders cheer CEO's roadmap for drug development following Nasdaq listing
$PMCB was the top trending ticker on Stocktwits as retail traders rallied around the stock's intrad…
Emily Graffeo
1 min read
Immunovant plunges nearly 50% after pausing a trial for its eye drug after unexpected cholesterol finding
Shares of Immunovant lost nearly half their value on Tuesday after the company announced a voluntar…
Isabelle Lee
1 min read
Cassava Sciences soars over 200% to 10-year high on positive Alzheimer's treatment data
Shares of the Austin, Texas-based drug maker neared 10-year highs after the company announced promi…
Isabelle Lee
1 min read
A small biopharma stock soars 198% after the company says it will seek FDA approval following a successful cancer-drug trial
Dr. Lan Huang, co-founder, CEO, and chair, said she will set a pre-non-disclosure agreement meeting…
Isabelle Lee
1 min read
GW Pharmaceuticals soars 46% after Jazz Pharma agrees to $7.2 billion acquisition of the CBD biopharma company
GW Pharma develops therapies derived from the marijuana plant, and was the first company to receive…
Matthew Fox
4 mins read
Markets witness choppy trading as realty, bank and auto indices drag
India’s benchmark indices Sensex and Nifty50 witnessed a see-saw movement in the first half of trad…
1 min read
Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue
The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…
Matthew Fox
2 mins read
Biopharma firm Adaptimmune spikes 330% after posting positive results for 4 tumor indicators
The confirmed PR in the liver cancer patient involved a 100% decrease in targeted lesions, the comp…
Ben Winck
1 min read
A small pharmaceutical company has surged 137% in 2 days after positive results in trials for lung disease treatment
aTyr says it plans to meet with the FDA to present its data on ATYR1923, a potential treatment for …
Carla Mozée
4 mins read
How to mine doge, plus a playbook for trading meme stocks
The definitive collection of the best investing stories Business Insider published during the week …
Joe Ciolli
2 mins read
A little-known biopharma firm surges 17% after getting FDA approval for the first-ever peanut allergy treatment
The Food and Drug Administration has approved for the first time a drug that treats peanut allergie…
Gwen Everett
2 mins read
3 biotechs that investors should buy next after Pfizer's $11 billion deal for cancer drugmaker Array BioPharma
Across these deals, a common theme is that companies have been eyeing drugs with strong research da…
Clarrie Feinstein,Emma Court
1 min read
GE is selling biopharma business sale to Danaher for $21.4 billion, reportedly calls off healthcare IPO
Get the latest General Electric stock price here.AP Images / Richard Drew
Rebecca Ungarino
1 min read
Moderna and BioNTech stocks are surging amid reports of FDA vaccine-approval progress
Moderna and BioNTech have climbed in recent weeks as the resurgent Delta variant has captured headl…
Ethan Wu
1 min read
SPAC engineering reaches new heights as scrapped deal sends pharma firm's stock plunging 36%
Drugmaker Roviant Sciences had been plotting a novel take on the popular SPAC deal, according to a …
Ethan Wu
3 mins read
Global equities find some footing after another slide in US tech stocks, led by a record fall in Tesla
Asian indices declined after the previous day saw tech favourites such as Apple, Amazon, Facebook, …
Shalini Nagarajan
1 min read
Stocks are tumbling
The first snapshot of the jobs market in April came in below expectations. ADP's report showed priv…
Akin Oyedele
3 mins read
Biocon was a hot stock before the latest earnings— from Tata Asset Management to Baroda AMC, at least five mutual fund houses added it to their portfolio
The biopharma major with a market value of over $5 billion blamed the COVID-19 crisis for the fa…